Mycobacteriophage–antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus

Bacteriophage therapy for infections in CF

(2021) Benjamin K. Chan et al.   PEDIATRIC PULMONOLOGY

Considerations for Phage Therapy Against Mycobacterium abscessus

(2021) Abrar Senhaji-Kacha et al.   Frontiers in Microbiology

Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis

(2021) Renee N. Ng et al.   Frontiers in Microbiology

Animal Models in the Evaluation of the Effectiveness of Phage Therapy for Infections Caused by Gram-Negative Bacteria from the ESKAPE Group and the Reliability of Its Use in Humans

(2021) Martyna Cieślik et al.   Microorganisms

Bacteriophage Therapy of Bacterial Infections: The Rediscovered Frontier

(2021) Nejat Düzgüneş et al.   Pharmaceuticals

Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection

(2021) Rebekah M. Dedrick et al.   NATURE MEDICINE

Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus

(2020) Matt D. Johansen et al.   NATURE REVIEWS MICROBIOLOGY

Efficacy of Bedaquiline, Alone or in Combination with Imipenem, against Mycobacterium abscessus in C3HeB/FeJ Mice

(2020) Vincent Le Moigne et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Large Extracellular Cord Formation in a Zebrafish Model of Mycobacterium kansasii Infection

(2020) Matt D Johansen et al.   JOURNAL OF INFECTIOUS DISEASES

Rifabutin is bactericidal against intracellular and extracellular forms of Mycobacterium abscessus

(2020) Matt D. Johansen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

CFTR Depletion Confers Hypersusceptibility to Mycobacterium fortuitum in a Zebrafish Model

(2020) Matt D. Johansen et al.   Frontiers in Cellular and Infection Microbiology

Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?

(2020) Tiffany Luong et al.   CLINICAL THERAPEUTICS

Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States

(2020) Saima Aslam et al.   Open Forum Infectious Diseases

Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro

(2019) James Dickey et al.   PLoS One

CFTR Protects against Mycobacterium abscessus Infection by Fine-Tuning Host Oxidative Defenses

(2019) Audrey Bernut et al.   Cell Reports

Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model

(2019) Marco Cafora et al.   Scientific Reports

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus

(2019) Rebekah M. Dedrick et al.   NATURE MEDICINE

The TetR-family transcription factor MAB_2299c regulates the expression of two distinct MmpS-MmpL efflux pumps involved in cross-resistance to clofazimine and bedaquiline in Mycobacterium abscessus

(2019) Ana Victoria Gutiérrez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Non-tuberculous mycobacterial pulmonary disease

(2019) Steven Cowman et al.   EUROPEAN RESPIRATORY JOURNAL

Dissecting erm(41)-Mediated Macrolide-Inducible Resistance in Mycobacterium abscessus

(2019) Matthias Richard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Case for Modeling Human Infection in Zebrafish

(2019) Margarida C. Gomes et al.   TRENDS IN MICROBIOLOGY

Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus

(2019) Clément Raynaud et al.   ACS Infectious Diseases

The Formation and Function of Granulomas

(2018) Antonio J. Pagán et al.   Annual Review of Immunology

High Levels of Intrinsic Tetracycline Resistance in Mycobacterium abscessus Are Conferred by a Tetracycline-Modifying Monooxygenase

(2018) Paulami Rudra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment

(2018) Michal Meir et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mutations in the MAB_2299c TetR Regulator Confer Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus

(2018) Matthias Richard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reinstating Mycobacterium massiliense and Mycobacterium bolletii as species of the Mycobacterium abscessus complex

(2017) Toidi Adekambi et al.   INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY

Elucidation of Mycobacterium abscessus aminoglycoside and capreomycin resistance by targeted deletion of three putative resistance genes

(2017) Anna Rominski et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Diverse Cellular and Animal Models to Decipher the Physiopathological Traits of Mycobacterium abscessus Infection

(2017) Audrey Bernut et al.   Frontiers in Cellular and Infection Microbiology

Nontuberculous Mycobacterial Infections in Cystic Fibrosis

(2016) Stacey L. Martiniano et al.   CLINICS IN CHEST MEDICINE

Intrinsic rifamycin resistance ofMycobacterium abscessusis mediated by ADP-ribosyltransferase MAB_0591

(2016) Anna Rominski et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence

(2016) Frank Oechslin et al.   JOURNAL OF INFECTIOUS DISEASES

Cystic fibrosis

(2016) J Stuart Elborn   LANCET

A new piperidinol derivative targeting mycolic acid transport inMycobacterium abscessus

(2016) Christian Dupont et al.   MOLECULAR MICROBIOLOGY

Mycobacterium abscessus-Induced Granuloma Formation Is Strictly Dependent on TNF Signaling and Neutrophil Trafficking

(2016) Audrey Bernut et al.   PLoS Pathogens

Susceptibility of Mycobacterium abscessus to Antimycobacterial Drugs in Preclinical Models

(2015) Andrés Obregón-Henao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis

(2015) Michael D. Parkins et al.   Journal of Cystic Fibrosis

Insights into the smooth-to-rough transitioning in Mycobacterium bolletii unravels a functional Tyr residue conserved in all mycobacterial MmpL family members

(2015) Audrey Bernut et al.   MOLECULAR MICROBIOLOGY

Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos

(2015) Audrey Bernut et al.   Jove-Journal of Visualized Experiments

In VivoAssessment of Drug Efficacy against Mycobacterium abscessus Using the Embryonic Zebrafish Test System

(2014) Audrey Bernut et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

 -Lactamase inhibition by avibactam in Mycobacterium abscessus

(2014) V. Dubee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation

(2014) A. Bernut et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Broadly Implementable Research Course in Phage Discovery and Genomics for First-Year Undergraduate Students

(2014) T. C. Jordan et al.   mBio

Zebrafish as a Novel Vertebrate Model To Dissect Enterococcal Pathogenesis

(2013) Tomasz K. Prajsnar et al.   INFECTION AND IMMUNITY

Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids

(2013) C. J. Cambier et al.   NATURE

Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish

(2013) Kevin Takaki et al.   Nature Protocols

Mycobacterium abscessus: a new antibiotic nightmare

(2012) R. Nessar et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

On the nature of mycobacteriophage diversity and host preference

(2012) Deborah Jacobs-Sera et al.   VIROLOGY

A Mycobacterium marinum TesA mutant defective for major cell wall-associated lipids is highly attenuated in Dictyostelium discoideum and zebrafish embryos

(2011) Laeticia Alibaud et al.   MOLECULAR MICROBIOLOGY

Burkholderia cenocepacia Creates an Intramacrophage Replication Niche in Zebrafish Embryos, Followed by Bacterial Dissemination and Establishment of Systemic Infection

(2010) A. C. Vergunst et al.   INFECTION AND IMMUNITY

A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae

(2009) K. A. Nash et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A novel vertebrate model ofStaphylococcus aureusinfection reveals phagocyte-dependent resistance of zebrafish to non-host specialized pathogens

(2008) Tomasz K. Prajsnar et al.   CELLULAR MICROBIOLOGY

Animal model of Mycobacterium abscessus lung infection

(2008) D. Ordway et al.   JOURNAL OF LEUKOCYTE BIOLOGY